Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021.

CONCLUSION: Introduction of tofacitinib to the formulary will provide 5-year savings, given the current drug price and patient volume.
PMID: 31178440 [PubMed - as supplied by publisher]

Source: Hong Kong Med J - May 28, 2019 Category: General Medicine Authors: Li X, Pathadka S, Man KK, Wong ICK, Chan EWY Tags: Hong Kong Med J Source Type: research